HighVista Strategies’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
BFA
BIT
SAM
SFM
LAM
HighVista Strategies's ANGO Position: Q4 2015 in Review
HighVista Strategies sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 290,406 shares — an estimated $3.83M sold.
HighVista Strategies first reported a position in ANGO in Q4 2014 and held it in 4 quarters. The position peaked at $5.56M in Q4 2014. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.
- HighVista Strategies reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
- HighVista Strategies sold 290,406 AngioDynamics shares in Q4 2015, an estimated $3.83M.
- HighVista Strategies first reported a position in AngioDynamics in Q4 2014 and held it in 4 quarters.
- HighVista Strategies's AngioDynamics position peaked at $5.56M in Q4 2014.
- 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.
Based on HighVista Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.